Navigation Links
Study Highlights Emerging Approaches to Medical Education in the Pharmaceutical Sector
Date:10/12/2011

CHAPEL HILL, N.C., Oct. 12, 2011 /PRNewswire/ -- The medical education landscape has changed dramatically for the pharmaceutical sector. As regulatory and market pressures have reshaped approaches to Continuing Medical Education programs, pharmaceutical organizations are struggling to have the right staffing, investment, and delivery platforms to provide valuable education opportunities for healthcare practitioners. 

To help inform medical education leaders on current approaches to medical education group size, service-levels, resources, and program deployment, Best Practices®, LLC conducted a new study, "Professional Medical Education Excellence: Structures, Resources, Services & Performance Levels to Optimize Pharmaceutical Education Groups." The study - which provides segments for both pharmaceutical and medical device leaders - presents medical education leaders' perspective on current and future trends for staffing and investment.

The study also informs education leaders on trends in the use of technology for education, the presence of education in emerging markets and how education groups are allocating their budget.

The research project found that on-demand Medical Education programs have proven popular in both pharma and device sectors as it offers busy physicians the flexibility to choose their timing for education. Almost 60 percent of the pharmaceutical segments' education programs in the past year were either on-demand or online Webcasts, according to the study.

This 85-page study covers the following topics:

  • Organizational Fit & Geographic Focus
  • Staffing Benchmarks & Program Trends
  • Roles for Key Activities & Program Deployment
  • Budget Benchmarks & Allocation Trends
  • Trends & Directions

The research project included observations and insights from 40 leaders with 35 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 10 medical device firms and 26 leaders from 25 biopharma companies. To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1127.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
2. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
3. Study Shows That Roches Investigational Drug for Alzheimers Disease Removes Amyloid Plaques From the Brain
4. Hernia Publishes a Unique Three Year Pre-Clinical Study of absorbable TIGR® Matrix Surgical Mesh Versus a Permanent Mesh
5. Hologic Announces Six-year Follow-up Results from the MammoSite Targeted Breast Irradiation Registry Study
6. Bioness Inc. Announces Completion of Enrollment in Its FASTEST L300 Study
7. FDA CONSUMER HEALTH INFORMATION -- Foreign Exporters Study Food Safety Law
8. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
9. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
10. Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival
11. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... provides drug pricing data and benchmarks in the global Autism Spectrum ... What are the key drugs marketed for Autism ...
(Date:2/23/2017)... CITY, Calif., Feb. 23, 2017 Nevro Corp. (NYSE: ... evidence-based solutions for the treatment of chronic pain, today reported ... December 31, 2016. 2016 Accomplishment & Highlights: ... full year 2016, an increase of 228% as reported, over ... for 2016, an increase of 612% over the prior year ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: ... networking and recognition opportunities as well as advocacy for the state and region‘s ... on February 23. The Council's Innovation Forecast event highlights innovation throughout the ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to ... Elite division on February 12th. Ms. Esparza qualified into this prestigious status ... competition held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... the La Gorce Country Club in Miami Beach to host its Swirl: Miami ...
Breaking Medicine News(10 mins):